Is Middle East Healthcare stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Middle East Healthcare pays dividends. Last time was Thursday 12th of July 2018 where the investors holding the stock on Monday 25th of June 2018 were paid SAR2 per share. Over the last 2 times between 2017 and 2018, Middle East Healthcare has paid SAR4 with an average of SAR2 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Middle East Healthcare 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SAR26.20, you would have made a profit of SAR48.30 per share or 184.35%
Yes, the average daily trading liquidity for Middle East Healthcare is SAR388 979 thousand. You should therefore be able to get in and out of your positions relatively fast.
Middle East Healthcare has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.07, the company's ability to pay off the debt is limited. Middle East Healthcare has a good net profit margin of 6.73% and should have high tolerances against inflation.
We have calculated the inflation risk for Middle East Healthcare to be medium [0.55 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.